Latest Office News

Alice Queen’s first 20 Horn Island RC holes all intersected mineralised geological features, with assays returning grades as high as 68.0g/t gold and extensions beyond the existing resource boundary. Nine assays remain pending as the company prepares to assess whether the results can support a larger resource and advance its development case.

GWR Group returned $19.85 million to shareholders during the September quarter, but its balance sheet remains exposed to unresolved Wiluna West liabilities. The company says $12.69 million in State royalties is overdue while the transfer of the tenements to Gold Valley remains incomplete.

RTG Mining says its Mabilo copper and gold project is moving towards a Final Investment Decision, with Glencore financing up to US$30 million of Stage 1 development. Permitting remains the critical hold-up, while fresh drilling at Chanach has produced no assays yet.

Felix Group lifted contracted ARR 10.6% year on year to $13.5 million in Q1 FY27, led by Nexvia and enterprise expansion. The software company ended September with $1.5 million in cash and estimated funding of just 1.12 quarters before the latest capital raising is fully available.

Syntara has reported statistically significant exploratory results for its Parkinson’s-related drug SNT-4728, while advancing blood-cancer and scar studies. The quarter also brought A$4.7 million in R&D funding, but the liquidation of a former buyer threatens a facility relocation and recovery of about A$0.6 million.

Kingsland Minerals ended the September quarter with $752,000 in cash and estimated funding for less than one quarter at current outgoings. Discussions with major shareholder Quinbrook remain non-binding, while the company has paused Leliyn exploration and is considering drilling its gold and uranium projects.

Canyon Resources has withdrawn its target for a first bauxite shipment in Q4 2026 after AFG Bank suspended further drawdowns on its Cameroon project facility. Rail and road infrastructure advanced, but port dredging, transhipping and a broader funding review now stand between the project and operations.

Earth’s Energy has completed its exit from its geothermal joint venture, but has yet to identify a replacement asset capable of supporting a return to the ASX board. The company ended September with A$1.613 million in cash and its securities still suspended.

H2G says its first PowerSafe stackable sodium-ion battery shipments have sold out, with products now available across Australia’s three eastern states. The company reported a sodium-ion sales pipeline above $4 million, alongside a $10 million-plus supercapacitor pipeline and quarter-end cash of $881,000.

Invex Therapeutics has paired its proposed acquisition of Rekover Therapeutics with a $10 million equity raising to fund a Phase 2a multiple sclerosis study and its existing Exenatide programs. The biotech ended September with A$3.59 million in cash, with shareholder approval still required for the larger part of the transaction.

Amara Minerals has reported broad gold intersections at its Apollo project in Victoria, including 102.3 metres at 2.29 g/t gold. The exploration momentum comes with just A$0.59 million in quarter-end cash and a stated need to assess further capital raising options.

BCAL Diagnostics has completed clinical validation for BREASTESTplus 2 across all breast densities and is targeting a November launch, while expanding Avantect Multicancer access. The commercial push comes alongside $1.895 million in quarterly operating cash outflows, only $580,000 in cash at quarter end and a growing strategic stake in Genetic Signatures.